Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors

Martijn van Essen; Dik J. Kwekkeboom; Wouter W. de Herder; Lisa Bodei; Boen L R Kam; Marion de Jong; Roelf Valkema; Eric P. Krenning

doi:10.1002/9780470613214.ch4

Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors

Martijn van Essen, Dik J. Kwekkeboom, Wouter W. de Herder, Lisa Bodei, Boen L R Kam, Marion de Jong, Roelf Valkema, Eric P. Krenning

Istituto Europeo di Oncologia

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English
Title of host publication	Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer
Publisher	John Wiley and Sons
Pages	121-138
Number of pages	18
ISBN (Print)	9780470243725
DOIs	https://doi.org/10.1002/9780470613214.ch4
Publication status	Published - Jul 15 2010

Keywords

Improving PRRT and future directions
Peptide Receptor Radionuclide Therapy (PRRT) in patients - with somatostatin receptor-positive neuroendocrine tumors
PRRT with radiolabeled somatostatin analogues - treatment modality for patients with inoperable or metastasized endocrine GEP tumors

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1002/9780470613214.ch4

Cite this

van Essen, M., Kwekkeboom, D. J., de Herder, W. W., Bodei, L., Kam, B. L. R., de Jong, M., Valkema, R., & Krenning, E. P. (2010). Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors. In Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer (pp. 121-138). John Wiley and Sons. https://doi.org/10.1002/9780470613214.ch4

Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors. / van Essen, Martijn; Kwekkeboom, Dik J.; de Herder, Wouter W.; Bodei, Lisa; Kam, Boen L R; de Jong, Marion; Valkema, Roelf; Krenning, Eric P.

Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer. John Wiley and Sons, 2010. p. 121-138.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

@inbook{e0ee21ba1d634973a08b22bc5a9b4fbd,

title = "Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors",

keywords = "Improving PRRT and future directions, Peptide Receptor Radionuclide Therapy (PRRT) in patients - with somatostatin receptor-positive neuroendocrine tumors, PRRT with radiolabeled somatostatin analogues - treatment modality for patients with inoperable or metastasized endocrine GEP tumors",

author = "{van Essen}, Martijn and Kwekkeboom, {Dik J.} and {de Herder}, {Wouter W.} and Lisa Bodei and Kam, {Boen L R} and {de Jong}, Marion and Roelf Valkema and Krenning, {Eric P.}",

year = "2010",

month = jul,

day = "15",

doi = "10.1002/9780470613214.ch4",

language = "English",

isbn = "9780470243725",

pages = "121--138",

booktitle = "Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer",

publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive Neuroendocrine Tumors

AU - van Essen, Martijn

AU - Kwekkeboom, Dik J.

AU - de Herder, Wouter W.

AU - Bodei, Lisa

AU - Kam, Boen L R

AU - de Jong, Marion

AU - Valkema, Roelf

AU - Krenning, Eric P.

PY - 2010/7/15

Y1 - 2010/7/15

KW - Improving PRRT and future directions

KW - Peptide Receptor Radionuclide Therapy (PRRT) in patients - with somatostatin receptor-positive neuroendocrine tumors

KW - PRRT with radiolabeled somatostatin analogues - treatment modality for patients with inoperable or metastasized endocrine GEP tumors

UR - http://www.scopus.com/inward/record.url?scp=84886199489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886199489&partnerID=8YFLogxK

U2 - 10.1002/9780470613214.ch4

DO - 10.1002/9780470613214.ch4

M3 - Chapter

AN - SCOPUS:84886199489

SN - 9780470243725

SP - 121

EP - 138

BT - Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer

PB - John Wiley and Sons

ER -